CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income	$ 58,361	$ 59,503
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	45,253	39,427
Change in fair value of derivative instruments	(39)	3
Reclassification of unrealized loss on derivative instruments into income	1,535	1,266
Write-downs and other charges, net	(1,031)	824
Amortization of debt discount and debt issuance costs	4,330	4,731
Interest - paid in kind	0	1,142
Share-based compensation	1,276	620
Earnings from joint ventures	(415)	(612)
Distributions from joint ventures	342	160
Loss on extinguishment/modification of debt	2,019	0
Changes in assets and liabilities:
Increase (Decrease) in Restricted Cash	(226)	0
Receivables, net	(2,007)	(1,551)
Interest on related party notes receivable	0	(185)
Inventories and prepaid expenses	(4,666)	(2,475)
Accounts payable	(393)	(1,862)
Accrued interest payable	(10,136)	(9,391)
Other accrued liabilities	1,475	4,219
Other, net	450	254
Net cash provided by operating activities	96,128	96,073
Cash flows from investing activities:
Capital expenditures, net of related payables	(41,333)	(31,301)
Proceeds from asset sales	523	0
Distributions in excess of earnings from joint ventures	432	0
Native American development costs	(798)	(386)
Other, net	(777)	(746)
Net cash used in investing activities	(41,953)	(32,433)
Cash flows from financing activities:
Borrowings under credit agreements with original maturity dates greater than three months	185,000	0
Payments under credit agreements with original maturities greater than three months	(209,143)	(48,892)
(Payments) borrowings under credit agreements with original maturity dates of three months or less, net	0	10,000
Capital Contribution	0	0
Distributions to members and noncontrolling interests	(15,491)	(8,347)
Payment of debt issuance costs	(16,861)	0
Payments on derivative instruments with other-than-insignificant financing elements	0	(1,786)
Payments on other debt	(1,398)	(1,361)
Payments to Acquire Additional Interest in Subsidiaries	(4,484)	0
Other, net	(6,119)	(7,316)
Net cash provided by (used in) financing activities	(68,496)	(57,702)
Cash and cash equivalents:
(Decrease) increase in cash and cash equivalents	(14,321)	5,938
Cash and Cash Equivalents, at Carrying Value	129,959	116,623
Cash and Cash Equivalents, at Carrying Value	115,638	122,561
Supplemental cash flow disclosures:
Cash paid for interest, net of $110 and $0 capitalized, respectively	38,718	39,088
Non-cash investing and financing activities:
Capital expenditures incurred but not yet paid	$ 29,330	$ 18,213